Biomarker, test method and test kit for predicting therapeutic effect of anti-VEGFR-2 antibody drug

摘要

By measuring VEGF-A, VEGF-D, sVEGFR-2, SDF-1α, and cNRP1, it is possible to predict the therapeutic effect and prognosis of anti-VEGFR-2 antibody drugs, particularly ramcilmab administration. An anti-VEGFR-2 antibody pharmaceutical, particularly a biomarker for predicting the effect of administration of ramucirumab, a test method using the marker, and a test kit can be provided. [Selection figure] None